Status:
COMPLETED
Short-Term Effect Of Ceriter Stride One (CSO) on FOG and Falling in pwP
Lead Sponsor:
University Ghent
Conditions:
Gait, Festinating
Parkinson Disease
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The Ceriter Stride One (CSO) is a "smart sole" with pressure sensors. The sole allows data on the displacement of the body's centre of gravity (COG), as well as spatiotemporal parameters, to be obtain...
Detailed Description
There is scientific evidence for making pwP stop at the onset of propulsion (when step length decreases and step frequency increases) in order to get the COG back within the base of support. Similarly...
Eligibility Criteria
Inclusion
- Parkinson's disease (or other Parkinsonism)
- gait impairment with freezing of gait (FOG)
- 18-80 years old
- I.C. (informed consent)
- Montreal Cognitive Assessment (MoCA) \>25
Exclusion
- unable to walk 4m without assistance
- MoCA \< 25
- no FOG
Key Trial Info
Start Date :
December 5 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 14 2024
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT06204081
Start Date
December 5 2023
End Date
May 14 2024
Last Update
June 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ghent University
Ghent, Oost-Vlaanderen, Belgium, 9000